| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/21/2004 | EP1439164A1 Novel phenylethanolamine compounds having beta2-acceptor excitatory function and their preparation method |
| 07/21/2004 | EP1438973A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 07/21/2004 | EP1438966A2 Use of depsipeptide and congeners thereof as immunosuppressants for treating an infectious disease, an autoimmune disease, allergic reactions or a hyperproliferative skin disease |
| 07/21/2004 | EP1438942A1 An otorhinological drug delivery device |
| 07/21/2004 | EP1438341A1 Antibody stimulating il-1ra production |
| 07/21/2004 | EP1438340A2 Antibodies against kdr, their production and uses |
| 07/21/2004 | EP1438316A1 Phosphonic acid compounds as inhibitors of serine proteases |
| 07/21/2004 | EP1438313A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 07/21/2004 | EP1438310A1 Beta-carbolin derivatives as ptp-inhibitors |
| 07/21/2004 | EP1438304A1 Novel substituted 4-phenyl-4- 1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 07/21/2004 | EP1438298A1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 07/21/2004 | EP1438295A2 Azole derivatives and pharmaceutical compositions containing them |
| 07/21/2004 | EP1438293A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 07/21/2004 | EP1438291A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 07/21/2004 | EP1438290A1 Cyclohept b!indole derivatives as spla2 inhibitors |
| 07/21/2004 | EP1438289A1 Indole derivatives as cox ii inhibitors |
| 07/21/2004 | EP1438071A1 Therapies for treating respiratory diseases |
| 07/21/2004 | EP1438061A2 Copolymers for suppression of autoimmune diseases, and methods of use |
| 07/21/2004 | EP1438053A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 07/21/2004 | EP1438052A1 INHIBITORS OF HUMAN PHOSPHATIDYL−INOSITOL 3−KINASE DELTA |
| 07/21/2004 | EP1438051A1 An enantiomerically pure diarylmethylpiperazine and methods of using same |
| 07/21/2004 | EP1438048A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 07/21/2004 | EP1438046A2 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 07/21/2004 | EP1438044A1 Bis-heteroaryl alkanes as therapeutic agents |
| 07/21/2004 | EP1438040A1 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt |
| 07/21/2004 | EP1438026A2 Taste masking spill-resistant formulation |
| 07/21/2004 | EP1438020A2 Topical compositions and methods for treating pain |
| 07/21/2004 | EP1438015A2 Cosmetic and dermopharmaceutical compositions for skin prone to acne |
| 07/21/2004 | EP1437961A2 Methods of suppressing microglial activation |
| 07/21/2004 | EP1437945A1 Use of cystathionine |
| 07/21/2004 | EP1331001B1 Novel dispersible and soluble galenic paracetamol formulation, method for its preparation and its applications |
| 07/21/2004 | EP1292608B1 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses |
| 07/21/2004 | EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/21/2004 | EP1147080B1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
| 07/21/2004 | EP1144369B1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 07/21/2004 | EP1131316B1 Improved chemical process and pharmaceutical formulation |
| 07/21/2004 | EP1077694B1 Aryl nitrone therapeutics for the treatment of inflammatory bowel disease |
| 07/21/2004 | EP0975604B1 Pyridazinones as inhibitors of cyclooxygenase-2 |
| 07/21/2004 | EP0958282B1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 07/21/2004 | CN1514831A Medicinal composition containing 1,3-thiazine derivative |
| 07/21/2004 | CN1514823A 草酸衍生物 Oxalic acid derivatives |
| 07/21/2004 | CN1514822A Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use |
| 07/21/2004 | CN1514736A Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers |
| 07/21/2004 | CN1514735A Ophthalmic composition comprising hyaluronic acid |
| 07/21/2004 | CN1514729A Sustained-release analgesic compounds |
| 07/21/2004 | CN1514723A Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 07/21/2004 | CN1514720A Self emulsifying lipid matrix (SELM) |
| 07/21/2004 | CN1513973A Fatly phospho embrella Pa-I.H bacterial strain and method of culturing fatty phospho embrella and medicine made from its active component |
| 07/21/2004 | CN1513971A Medical health protection type deer bone (glue) wine |
| 07/21/2004 | CN1513861A Ibuprofen sugar conjugated product and its preparation method and application |
| 07/21/2004 | CN1513526A Blood nourishing and toxin resolving medicine for treating AIDS |
| 07/21/2004 | CN1513524A Special effect medicine for pyretolysis |
| 07/21/2004 | CN1513523A Chinese medicinal composition for enhancing immune function and preventing and treating homogus rheumatism hyperrosteogeny |
| 07/21/2004 | CN1513511A Nano medicinal plaster for treating rheumatism and nomologous rheumatism and its preparation method |
| 07/21/2004 | CN1513507A Chrysanthem pain relieving medicinal preparation |
| 07/21/2004 | CN1513505A Method for preparing qingkailing granules |
| 07/21/2004 | CN1513499A Process for preparing capsule for invigorating circulation of blood and relieving pain |
| 07/21/2004 | CN1513496A Traditional chinese tablet for treating enteric disease and nasosinusitis and its prepn. method |
| 07/21/2004 | CN1513480A Artificial bear gall |
| 07/21/2004 | CN1513459A Freeze-dried powder injection contg. metallic complex of ethylenediamine teramethylene phosphoric acid, and its prepn. method |
| 07/21/2004 | CN1513446A Injection of sodium bouttuynin, and its prepn. method |
| 07/21/2004 | CN1513442A Prepn. and use of mixture of arginine-burfenum |
| 07/21/2004 | CN1158386C Polynucleotides isolated from skin cells and methods for their use |
| 07/21/2004 | CN1158302C Arginine-aescin with functions of detumescence, relieving inflammation and improving blood circulation and its preparing process |
| 07/21/2004 | CN1158297C Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/21/2004 | CN1158283C 4,5-pyrazinoxindoles as protein kinase inhibitors |
| 07/21/2004 | CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 07/21/2004 | CN1158266C Compounds |
| 07/21/2004 | CN1158102C Chinese medicine for treating nocturnal fever |
| 07/21/2004 | CN1158099C Medicine for treating osteoarthritis and its preparing process and application |
| 07/21/2004 | CN1158095C Chinese medicine for treating rheumatoid arthritis |
| 07/21/2004 | CN1158093C Medicine composition containing yak bone for treating rhenmatism and method for making same |
| 07/20/2004 | US6765013 Thiazolidinedione derivatives for the treatment of diabetes and other diseases |
| 07/20/2004 | US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
| 07/20/2004 | US6765010 Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 07/20/2004 | US6765008 Pyrrolopyrimidines as CRF antagonists |
| 07/20/2004 | US6765003 3-Arylsulfonyl-2 (substituted methyl) propanoic acid derivatives as matrix metalloproteinase inhibitors |
| 07/20/2004 | US6765001 Mixture with penetration intensifiers, solvents and emulsifiers |
| 07/20/2004 | US6764838 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 07/20/2004 | US6764826 Detcting modulators of c-reactive proteins; obtain c-reactive protein, incubate with modulator, monitor binding between reactive protein and modulator |
| 07/20/2004 | US6764693 Free radical quenching composition and a method to increase intracellular and/or extracellular antioxidants |
| 07/20/2004 | CA2292388C Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 07/20/2004 | CA2257136C Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors |
| 07/20/2004 | CA2254731C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids |
| 07/15/2004 | WO2004058804A1 Peptides and therapeutic uses thereof |
| 07/15/2004 | WO2004058788A1 Lipid a analogues having glucose as the right sugar |
| 07/15/2004 | WO2004058778A1 New phosphoramide derivatives |
| 07/15/2004 | WO2004058772A1 Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same |
| 07/15/2004 | WO2004058767A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 07/15/2004 | WO2004058754A1 Benzoazolypiperazine derivatives having mglur1- and mglur5-antagonistic activity |
| 07/15/2004 | WO2004058742A1 Benzocycloheptapyridine compounds |
| 07/15/2004 | WO2004058736A1 Ccr8 inhibitors |
| 07/15/2004 | WO2004058733A1 Non-steroidal anti-inflammatory agents |
| 07/15/2004 | WO2004058709A1 Ccr8 inhibitors |
| 07/15/2004 | WO2004058697A1 4-nitro-2-[(4'-methoxy)-phenoxy]-methanesulfonanilide derivates and their pharmaceutical use |
| 07/15/2004 | WO2004058275A2 Compositions of magnetic particles covered with gem-bisphosphonate derivatives |
| 07/15/2004 | WO2004058042A2 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases |
| 07/15/2004 | WO2004046092A3 Aryl sulfonamides |
| 07/15/2004 | WO2004045536A3 Method and compositions for temporarily incapaciting subjets |
| 07/15/2004 | WO2004041163A3 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |